Navigation Links
Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
Date:3/4/2008

vailable in the

U.S.

-- IPLEX(TM)

-- Made IPLEX(TM) available to physicians in Italy at the request of

the Italian Ministry of Health to treat patients with Amyotrophic

Lateral Sclerosis ("ALS"), also known as Lou Gehrig's Disease,

through an expanded access program ("EAP"), with the Company

receiving cost recovery payments for IPLEX(TM) from the Italian

Health Authorities. EAP currently includes 15 physicians and

approximately 70 subjects, and the Company received cost recovery

of $5.4 million for IPLEX(TM) supplied to the EAP in the full-year

2007;

-- Announced positive results from a Phase 2 investigator-sponsored

study of IPLEX(TM) in six patients with myotonic muscular

dystrophy ("MMD") that met the primary study endpoints of being

safe and well-tolerated, and indicated improvements in patients'

muscle mass, cholesterol and triglycerides;

-- Initiated a 24-week, multi-center, randomized, double blind,

placebo-controlled Phase 3 enabling clinical trial with IPLEX(TM)

in 60 patients with MMD;

-- Awarded a grant of $2.1 million from the Muscular Dystrophy

Association ("MDA"), which is expected to cover a substantial

portion of the external costs associated with the MMD trial;

-- Granted Orphan Drug designation for IPLEX(TM) for the treatment of

MMD by the FDA, providing the Company with, among other important

benefits, seven years of market exclusivity upon approval of

IPLEX(TM) for the MMD indication; and

-- Completed an external assessment of the total market for MMD

treatments that indicated that the market for MMD could be as high

as between $800 million and $1.4 billion.

"We
'/>"/>

SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
2. Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
3. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
4. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
5. Insmed to Appeal Delisting Notification From Nasdaq
6. Insmed Awarded $2.1 Million by Muscular Dystrophy Association
7. Insmed Appoints Dennis M. Lanfear to Board Of Directors
8. Barr Announces Favorable Ruling in Yasmin(R) Patent Challenge
9. Vermillion Announces Effectiveness of Reverse Stock Split
10. Rosetta Genomics Announces Allowance of Two Additional microRNA Patents
11. ROBODOC(R) Announces Patent Cross Licensing Agreement With IBM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... PORTOLA VALLEY, Calif. , July 31, 2014 /PRNewswire/ ... San Francisco Bay Area , has ... the University of Oxford,s commercialisation company. The potent anti-inflammatory ... David Greaves at the University of Oxford,s Sir ... The company, which has raised over $1.5 million ...
(Date:7/31/2014)... Francisco, California (PRWEB) July 31, 2014 ... systems that inform therapeutic decision-making in oncology, today announced ... August 14, 2014 to discuss the Company's financial results ... provide an update about the business in the current ... audio call beginning on Thursday, August 14, 2014, at ...
(Date:7/31/2014)... 2014 Rancho BioSciences , the ... Omicsoft’s Array Suite with tranSMART . Scientists ... to send data in tranSMART to Array Suite for ... of tranSMART including the new 1.2 release. Array ... storage for the analysis of high dimensional quantification data, ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 ... and collaboration company, is proud to announce the ... LMS complements Adobe Connect’s elearning tools to quickly ... delivers content with training tools for desktop and ... with LMS is the perfect online training solution, ...
Breaking Biology Technology:Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 2Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 3CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update 2Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 2Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 3SoundConnect Enhances Portfolio with Adobe Connect Learning Management System (LMS) 2
... 9 Burrill Merchant Banking acted as,exclusive financial ... partnering of bilastine with the Menarini Group (Italy). ... bilastine rights in Europe,and other regions to Menarini ... is a new highly selective H1 antihistamine for ...
... 9 Barr Pharmaceuticals,Inc. (NYSE: BRL ) ... a challenge of the patents listed by Sanofi-Aventis ... Solution), 5mg/mL,Injectable., Barr filed an Abbreviated New ... a generic Eloxatin product with the U.S.,Food & ...
... Quintiles,Transnational Corp. today announced the expansion and consolidation ... (CDS) units,in Beijing to accommodate their growing business ... facility, with more than 17,000,square feet of space, ... Beijing, about,one block from the previous lab site ...
Cached Biology Technology:Burrill Merchant Banking Advises Faes Farma on Bilastine Licensing Agreement 2Barr Confirms Patent Challenge of Eloxatin(R) Injectable, 5mg/mL 2Barr Confirms Patent Challenge of Eloxatin(R) Injectable, 5mg/mL 3Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility 2
(Date:7/31/2014)... , July 31, 2014 NXT-ID, Inc., ... growing m-commerce market, reminds investors and consumers wanting ... wallet, Wocket™, that it will be on-air today, July ... Wocket smart wallet will be featured in a ... television show that airs on the History Channel, ...
(Date:7/30/2014)... The black truffle uses reversible epigenetic processes to regulate ... The ,methylome, - a picture of the genome regulation ... open access journal Genome Biology and illustrates ... elements and ,jumping genes,. The authors say this may ... are controlled. , Black truffles (Tuber melanosporum), also known ...
(Date:7/30/2014)... potential effects of climate change on the world,s ... wrong factors, according to a new paper by ... University of Queensland, and other organizations. The authors ... missing the point when it comes to climate ... change scientists focus on the "direct" threats of ...
Breaking Biology News(10 mins):NXT-ID's Next Generation Biometric Smart Wallet Featured on NewsWatch Consumer Show on the History Channel and FYI Network Today, July 31st 2NXT-ID's Next Generation Biometric Smart Wallet Featured on NewsWatch Consumer Show on the History Channel and FYI Network Today, July 31st 3How black truffles deal with the jumpers in their genome 2Conservation scientists asking wrong questions on climate change impacts on wildlife 2
... health in the past, and are bound to do ... example, led to many illnesses and deaths from breathing ... vying for scarce food, shelter, and work. Future ... ramifications. Following a request from Gov. Christine Gregoire, Washington ...
... colds? How do viruses get into cells? In pursuing this ... since 1997, and his team have pioneered research in this ... the Swiss Nobel Prize in Bern, Switzerland. This award is ... well a confirmation of our long years of work, and ...
... #1 FOR IMMEDIATE RELEASE Spinning a new role ... and DVDs and the hardware used to play these popular ... a new generation of portable, inexpensive instruments for home health ... in the Oct. 15 issue of ACS Analytical Chemistry, a ...
Cached Biology News:University and state agencies to forecast local health effects of climate change 2University and state agencies to forecast local health effects of climate change 3University and state agencies to forecast local health effects of climate change 4ETH Zurich professor Ari Helenius awarded Benoist Prize 2American Chemical Society's Weekly PressPac -- Sept. 19, 2007 2American Chemical Society's Weekly PressPac -- Sept. 19, 2007 3American Chemical Society's Weekly PressPac -- Sept. 19, 2007 4American Chemical Society's Weekly PressPac -- Sept. 19, 2007 5American Chemical Society's Weekly PressPac -- Sept. 19, 2007 6American Chemical Society's Weekly PressPac -- Sept. 19, 2007 7American Chemical Society's Weekly PressPac -- Sept. 19, 2007 8
Human/Mouse G9a/EHMT2 MAb (Clone A8620A) Keywords: Eu-HMTase2...
Human M-CSF...
Human Serpin B5/Maspin Affinity Purified Polyclonal Ab...
... (1995) This book contains up ... current issues relating to the aetiology and ... have been made recently which greatly improve ... molecular neuropathology through clinical and diagnostic aspects, ...
Biology Products: